Nuvation Bio price target raised to $13 from $11 at Truist

2 hours ago 2

TipRanks

Wed, January 28, 2026 astatine 7:28 AM CST 1 min read

Truist raised the firm’s price target connected Nuvation Bio (NUVB) to $13 from $11 and keeps a Buy standing connected the shares arsenic portion of a broader probe enactment previewing Q4 net successful Biotech. The steadfast believes the Ibtrozi franchise has shown robust accidental retired of the gate, with stronger-than-anticipated uptake, contempt seasonal headwinds, positioning Ibtrozi arsenic the ROS1 cause of prime versus competitors, the expert tells investors successful a probe note.

Unlock hedge fund-level information and almighty investing tools for smarter, sharper decisions
Stay up of the marketplace with the latest quality and investigation and maximize your portfolio's potential

Published archetypal connected TheFly – the eventual root for real-time, market-moving breaking fiscal news. Try Now>>

See Insiders’ Hot Stocks connected TipRanks >>

Read More connected NUVB:

Disclaimer & DisclosureReport an Issue

Nuvation Bio terms people raised to $12 from $9 astatine RBC Capital
Nuvation Bio shares charismatic connected weakness, says B. Riley
Nuvation Bio falls -17.3%
Nuvation Bio terms people lowered to $17 from $18 astatine H.C. Wainwright
Nuvation Bio Expands Global Reach with Eisai Partnership

Read Entire Article